Opioid agonist treatment and patient outcomes during the COVID‐19 pandemic in south east Sydney, Australia

N Lintzeris, RM Deacon, V Hayes… - Drug and alcohol …, 2022 - Wiley Online Library
Introduction In early 2020, many services modified their delivery of opioid treatment in
response to the COVID‐19 pandemic, to limit viral spread and maintain treatment continuity …

Assessing the concurrent validity, inter‐rater reliability and test–re‐test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment …

RM Deacon, K Mammen, R Bruno, L Mills, A Dunlop… - …, 2021 - Wiley Online Library
Abstract Background and Aims The Australian Treatment Outcomes Profile (ATOP) is a brief
instrument measuring recent substance use, risk profile and general health and wellbeing …

[HTML][HTML] 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow …

M Farrell, J Shahbazi, M Chambers, M Byrne… - International Journal of …, 2024 - Elsevier
Background The most recent formulation of buprenorphine treatment is extended-release
depot injections (BUP-XR) that are administered subcutaneously by health care …

The impact of changes in opioid dependency treatment upon COVID-19 transmission in Sydney, Australia: a retrospective longitudinal observational study

BT Trevitt, V Hayes, R Deacon, L Mills, A Demirkol… - BMC Public Health, 2024 - Springer
Abstract Background In April 2020, in response to the COVID-19 public health emergency,
South Eastern Sydney Local Health District (SESLHD) Drug and Alcohol services modified …

An international, multidisciplinary consensus set of patient-centered outcome measures for substance-related and addictive disorders

N Black, S Chung, C Tisdale, LS Fialho… - Journal of clinical …, 2024 - mdpi.com
Background: In 1990, the United States' Institute of Medicine promoted the principles of
outcomes monitoring in the alcohol and other drugs treatment field to improve the evidence …

Integration of a facilitated access pathway for contraception into alcohol and other drug treatment services: A cohort study comparing metropolitan and regional …

KA McNamara, B Murnion, N Lintzeris… - Drug and Alcohol …, 2024 - Wiley Online Library
Introduction Women who attend alcohol and other drug (AOD) services experience higher
rates of unintended pregnancy, and access less contraception, than the general population …

Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions

K Mammen, L Mills, RM Deacon, R Bruno… - Drug and Alcohol …, 2022 - Wiley Online Library
Abstract Introduction The Australian Treatment Outcomes Profile (ATOP) is a brief instrument
that measures self‐reported substance use, health, and wellbeing in the previous 28 days …

Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile

RM Deacon, L Mills, R Bruno, K Mammen, A Dunlop… - …, 2023 - Wiley Online Library
Abstract Aims The Austraian Treatment Outcomes Profile (ATOP) is a brief clinical outcomes
tool used widely in the Australian alcohol and other drugs treatment sector to monitor clients' …

New South Wales alcohol and other drug service providers' perceptions of the relative importance of client variables for determining treatment need

B Larance, I Ingram, C Haynes… - Drug and Alcohol …, 2024 - Wiley Online Library
Introduction This study examines alcohol and other drug (AOD) service providers'
perceptions of the most important variables (client complexity and demographic) for …

Community‐based counselling for benzodiazepine withdrawal: A mixed‐methods study of client outcomes

G Wurf, P O'Neal - Counselling and Psychotherapy Research, 2022 - Wiley Online Library
Despite adverse health outcomes being associated with long‐term tranquilliser use, health
professionals face numerous barriers in reducing reliance on benzodiazepines. This study …